PARK7 and pancreatic neoplasm: Our results are in the agreement with previous studies which showed that overexpression of DJ-1 can increase the drug resistance of cancer cells including pancreatic cancer [24], nonsmall cell lung cancer (NSCLC) [25], and leukemia [26].